CLINICAL_TRIALS
trial_result
· 2018-07-10
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of erenumab (AMG 334) for migraine prevention has completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2018-07-10